Study – Page 3 – JoelGalvan

Business

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

14 min read

Posted on February 22, 2025

by Joelgalvan

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…

Culture

2 min read

Posted on February 14, 2025

by Joelgalvan

Zach Condon has announced a new Beirut album, A Study of Losses, which will arrive on April 18 on his…